Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -14.76 | 11.09 |
| PEG Ratio (TTM) | 0.03 | -1.98 |
| P/S Ratio (TTM) | 0.89 | 2.28 |
| P/B Ratio (TTM) | 0.25 | 2.11 |
| P/FCF Ratio (TTM) | -0.93 | 20.44 |
| Price to 5YR AVG Earnings Ratio | -31.12 | 13.02 |
| Price to 5YR AVG FCF Ratio | -2.55 | 19.20 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -1.29% | 3.33% |
| ROE (TTM) | -1.74% | 13.46% |
| Net Profit Margin (TTM) | -5.92% | -20.79% |
| ROIC 5YR AVG | -5.71% | 9.91% |
Growth (52%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -173.11% | 64.97% | 27.66% |
| Revenue | 4.12% | -1.22% | 6.00% |
| Net Income | -267.65% | 83.05% | 38.60% |
| Cash Flow | -164.35% | -96.58% | 2,442.69% |
Health (51%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.26 | 2.18 |
| Quick Ratio (TTM) | 2.55 | 1.28 |
| D/E Ratio (TTM) | 0.21 | 1.01 |
| Interest Coverage (TTM) | -10.23 | -11.62 |
| Piotroski F-Score | 5 | 7 |
| Altman Z-Score | 1.29 | 3.84 |
| LTL to 5YR AVG FCF | -0.20 | 7.58 |
| Shares Outstanding Growth 5YR AVG | 9.75% | 8.57% |